These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9040924)

  • 21. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 23. Wisconsin Card Sorting Test performance over time in schizophrenia. Preliminary evidence from clinical follow-up and neuroleptic reduction studies.
    Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Cassens G; McCarley RW; Tsuang MT
    Schizophr Res; 1991 Oct; 5(3):233-42. PubMed ID: 1684721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Extended" antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.
    Remington G; Seeman P; Feingold A; Mann S; Shammi C; Kapur S
    J Clin Psychiatry; 2011 Aug; 72(8):1042-8. PubMed ID: 20868639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
    Chiu H; Lee S; Leung CM; Wing YK
    Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosaging patterns in schizophrenia with depot, oral and combined neuroleptic therapy.
    Remington GJ; Prendergast P; Bezchlibnyk-Butler KZ
    Can J Psychiatry; 1993 Apr; 38(3):159-61. PubMed ID: 8098988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic dosing and neuroleptic plasma levels in schizophrenia: determining the optimal regimen.
    Shriqui CL
    Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S38-48. PubMed ID: 8564916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.
    Lindström EM; Ohlund LS; Lindström LH; Ohman A
    Psychiatry Res; 1992 May; 42(2):145-58. PubMed ID: 1352902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.
    Evans JD; Negron AE; Palmer BW; Paulsen JS; Heaton RK; Jeste DV
    J Geriatr Psychiatry Neurol; 1999; 12(1):11-5. PubMed ID: 10447149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Algorithm for treatment-refractory schizophrenia.
    Koshino Y
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment.
    Higuchi H; Kamata M; Yoshimoto M; Shimisu T; Hishikawa Y
    Psychiatry Clin Neurosci; 1999 Feb; 53(1):91-4. PubMed ID: 10201291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries.
    Barbui C; Nosè M; Mazzi MA; Thornicroft G; Schene A; Becker T; Bindman J; Leese M; Helm H; Koeter M; Weinmann S; Tansella M
    Int Clin Psychopharmacol; 2006 Nov; 21(6):355-62. PubMed ID: 17012982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic dose reduction for schizophrenic outpatients: a three-year follow-up study.
    Faraone SV; Cirelli V; Curran JP; Brown WA
    Hosp Community Psychiatry; 1988 Nov; 39(11):1207-8. PubMed ID: 2906321
    [No Abstract]   [Full Text] [Related]  

  • 35. Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia.
    Suzuki T; Uchida H; Takeuchi H; Nomura K; Tanabe A; Watanabe K; Yagi G; Kashima H
    Psychopharmacology (Berl); 2005 Sep; 181(3):566-75. PubMed ID: 15991004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arguments for early treatment of refractory schizophrenia].
    Lombertie ER; Salome N; Villegier P; Laghrissi-Thode F; Nassif F
    Encephale; 1995 Jun; 21 Spec No 3():29-33. PubMed ID: 7628338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
    Hirschowitz J; Hitzemann R; Piscani K; Burr G; Frecska E; Culliton D; Mann M; Curtis C
    Schizophr Res; 1997 Jan; 23(1):31-43. PubMed ID: 9050126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.